Literature DB >> 18578745

Prospective community-based cluster census and case-control study of stillbirths and neonatal deaths in the West Bank and Gaza Strip.

Henry D Kalter1, Reem Rahil Khazen, Mustafa Barghouthi, Mohammed Odeh.   

Abstract

Obstetric complications and newborn illnesses amenable to basic medical interventions underlie most perinatal deaths. Yet, despite good access to maternal and newborn care in many transitional countries, perinatal mortality is often not monitored in these settings. The present study identified risk factors for perinatal death and the level and causes of stillbirths and neonatal deaths in the West Bank and Gaza Strip. Baseline and follow-up censuses with prospective monitoring of pregnant women and newborns from September 2001 to August 2002 were conducted in 83 randomly selected clusters of 300 households each. A total of 113 of 116 married women 15-49 years old with a stillbirth or neonatal death and 813 randomly selected women with a surviving neonate were interviewed, and obstetric and newborn care records of women with a stillbirth or neonatal death were abstracted. The perinatal and neonatal mortality rates, respectively, were 21.2 [95% confidence interval (CI) 16.5, 25.9] and 14.7 [95% CI 10.2, 19.2] per 1000 livebirths. The most common cause (27%) of 96 perinatal deaths was asphyxia alone (21) or with neonatal sepsis (5), while 18/49 (37%) early and 9/19 (47%) late neonatal deaths were from respiratory distress syndrome (12) or sepsis (9) alone or together (6). Constraint in care seeking, mainly by an Israeli checkpoint, occurred in 8% and 10%, respectively, of 112 pregnancies and labours and 31% of 16 neonates prior to perinatal or late neonatal death. Poor quality care for a complication associated with the death was identified among 40% and 20%, respectively, of 112 pregnancies and labour/deliveries and 43% of 68 neonates. (Correction added after online publication 5 June 2008: The denominators 112 pregnancies, labours, and labour/deliveries, and 16 and 68 neonates were included; and 9% of labours was corrected to 10%.) Risk factors for perinatal death as assessed by multivariable logistic regression included preterm delivery (odds ratio [OR] = 11.9, [95% CI 6.7, 21.2]), antepartum haemorrhage (OR = 5.6, [95% CI 1.5, 20.9]), any severe pregnancy complication (OR = 3.4, [95% CI 1.8, 6.6]), term delivery in a government hospital and having a labour and delivery complication (OR = 3.8, [95% CI 1.2, 12.0]), more than one delivery complication (OR = 4.4, [95% CI 1.8, 10.5]), mother's age >35 years (OR = 2.9, [95% CI 1.3, 6.8]) and primiparity in a full-term pregnancy (OR = 2.6, [1.1, 6.3]). Stillbirths are not officially reportable in the West Bank and Gaza Strip and this is the first time that perinatal mortality has been examined. Interventions to lower stillbirths and neonatal deaths should focus on improving the quality of medical care for important obstetric complications and newborn illnesses. Other transitional countries can draw lessons for their health care systems from these findings.

Entities:  

Mesh:

Year:  2008        PMID: 18578745     DOI: 10.1111/j.1365-3016.2008.00943.x

Source DB:  PubMed          Journal:  Paediatr Perinat Epidemiol        ISSN: 0269-5022            Impact factor:   3.980


  9 in total

1.  Spatial pattern of perinatal mortality and its determinants in Ethiopia: Data from Ethiopian Demographic and Health Survey 2016.

Authors:  Tesfaye Assebe Yadeta; Bizatu Mengistu; Tesfaye Gobena; Lemma Demissie Regassa
Journal:  PLoS One       Date:  2020-11-23       Impact factor: 3.240

2.  Low infant mortality among Palestine refugees despite the odds.

Authors:  Flavia Riccardo; Ali Khader; Guido Sabatinelli
Journal:  Bull World Health Organ       Date:  2011-02-17       Impact factor: 9.408

Review 3.  Data collection tools for maternal and child health in humanitarian emergencies: a systematic review.

Authors:  Thidar Pyone; Fiona Dickinson; Robbie Kerr; Cynthia Boschi-Pinto; Matthews Mathai; Nynke van den Broek
Journal:  Bull World Health Organ       Date:  2015-06-24       Impact factor: 9.408

4.  Correlates of poor perinatal outcomes in non-hospital births in the context of weak health system: the Nigerian experience.

Authors:  Peter Onubiwe Nkwo; Lucky Osaheni Lawani; Euzebus Chinonye Ezugwu; Chukwuemeka Anthony Iyoke; Agozie C Ubesie; Robinson Chukwudi Onoh
Journal:  BMC Pregnancy Childbirth       Date:  2014-09-30       Impact factor: 3.007

Review 5.  When do newborns die? A systematic review of timing of overall and cause-specific neonatal deaths in developing countries.

Authors:  M J Sankar; C K Natarajan; R R Das; R Agarwal; A Chandrasekaran; V K Paul
Journal:  J Perinatol       Date:  2016-05       Impact factor: 2.521

6.  Maternal characteristics and obstetrical complications impact neonatal outcomes in Indonesia: a prospective study.

Authors:  Trisari Anggondowati; Ayman A E El-Mohandes; S Nurul Qomariyah; Michele Kiely; Judith J Ryon; Reginald F Gipson; Benjamin Zinner; Anhari Achadi; Linda L Wright
Journal:  BMC Pregnancy Childbirth       Date:  2017-03-28       Impact factor: 3.007

7.  Use of verbal autopsy and social autopsy in humanitarian crises.

Authors:  Lisa-Marie Thomas; Lucia D'Ambruoso; Dina Balabanova
Journal:  BMJ Glob Health       Date:  2018-05-03

8.  Making stillbirths count, making numbers talk - issues in data collection for stillbirths.

Authors:  J Frederik Frøen; Sanne J Gordijn; Hany Abdel-Aleem; Per Bergsjø; Ana Betran; Charles W Duke; Vincent Fauveau; Vicki Flenady; Sven Gudmund Hinderaker; G Justus Hofmeyr; Abdul Hakeem Jokhio; Joy Lawn; Pisake Lumbiganon; Mario Merialdi; Robert Pattinson; Anuraj Shankar
Journal:  BMC Pregnancy Childbirth       Date:  2009-12-17       Impact factor: 3.007

9.  Verbal/social autopsy study helps explain the lack of decrease in neonatal mortality in Niger, 2007-2010.

Authors:  Henry D Kalter; Asma Gali Yaroh; Abdou Maina; Alain K Koffi; Khaled Bensaïd; Agbessi Amouzou; Robert E Black
Journal:  J Glob Health       Date:  2016-06       Impact factor: 4.413

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.